FIBROGEN INC Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Fibrogen Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • Fibrogen Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$1.28M, a 148% decline year-over-year.
  • Fibrogen Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $8.08M, a 26.1% increase year-over-year.
  • Fibrogen Inc annual Nonoperating Income (Expense) for 2023 was $10.5M, a 38% increase from 2022.
  • Fibrogen Inc annual Nonoperating Income (Expense) for 2022 was $7.6M.
  • Fibrogen Inc annual Nonoperating Income (Expense) for 2021 was -$1.08M, a 119% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.5M +$2.88M +38% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $7.6M +$8.67M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 -$1.08M -$6.63M -119% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $5.55M -$10M -64.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $15.5M Jan 1, 2019 Dec 31, 2019 10-K/A 2022-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.